Pulse Biosciences Inc (PLSE) — Cash Flow-to-Debt Ratio
Pulse Biosciences Inc (PLSE) has a Cash Flow-to-Debt Ratio of -0.95x as of December 2025, meaning its operating cash flow of $-14.76 Million could theoretically repay -1% of its total liabilities ($15.46 Million) in one year. Explore Pulse Biosciences Inc operating cash flow efficiency to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pulse Biosciences Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Pulse Biosciences Inc across 12 annual periods. Also explore PLSE asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Pulse Biosciences Inc (2014–2025)
Year-by-year debt coverage analysis for Pulse Biosciences Inc. For market capitalisation and broader financial context, see market cap of Pulse Biosciences Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.50x | $-54.12 Million | $15.46 Million | ▼ -69.5% |
| 2024 | -2.07x | $-36.34 Million | $17.60 Million | ▲ +7.5% |
| 2023 | -2.23x | $-33.04 Million | $14.79 Million | ▼ -280.6% |
| 2022 | -0.59x | $-47.01 Million | $80.12 Million | ▲ +79.9% |
| 2021 | -2.91x | $-54.10 Million | $18.56 Million | ▼ -51.6% |
| 2020 | -1.92x | $-35.37 Million | $18.40 Million | ▲ +37.1% |
| 2019 | -3.06x | $-34.19 Million | $11.18 Million | ▲ +44.9% |
| 2018 | -5.55x | $-23.90 Million | $4.31 Million | ▼ -91.5% |
| 2017 | -2.90x | $-11.09 Million | $3.83 Million | ▲ +63.4% |
| 2016 | -7.92x | $-8.05 Million | $1.02 Million | ▼ -57.6% |
| 2015 | -5.03x | $-3.32 Million | $659.76K | ▼ -5188.7% |
| 2014 | -0.10x | $-173.14K | $1.82 Million | — |